Re: Holz et al.: Adherence to intravitreal aflibercept in neovascular age-related macular degeneration: 24-month results from the ANDROMEDA Study (Ophthalmol. Retina. 2026;10:241-249).

Manikya S, Vadhithala V, Kumar R, Nainwal P

Open source

DOI
10.1016/j.oret.2026.06.013
Published
2026 Sep
Container
Ophthalmology. Retina
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.oret.2026.06.013,
  title = {Re: Holz et al.: Adherence to intravitreal aflibercept in neovascular age-related macular degeneration: 24-month results from the ANDROMEDA Study (Ophthalmol. Retina. 2026;10:241-249).},
  author = {Manikya S and Vadhithala V and Kumar R and Nainwal P},
  year = {2026},
  journal = {Ophthalmology. Retina},
  doi = {10.1016/j.oret.2026.06.013},
  url = {https://doi.org/10.1016/j.oret.2026.06.013}
}

RIS

TY  - JOUR
TI  - Re: Holz et al.: Adherence to intravitreal aflibercept in neovascular age-related macular degeneration: 24-month results from the ANDROMEDA Study (Ophthalmol. Retina. 2026;10:241-249).
AU  - Manikya S
AU  - Vadhithala V
AU  - Kumar R
AU  - Nainwal P
PY  - 2026
JO  - Ophthalmology. Retina
DO  - 10.1016/j.oret.2026.06.013
UR  - https://doi.org/10.1016/j.oret.2026.06.013
ER  - 

APA

S, M., V, V., R, K., & P, N. (2026). Re: Holz et al.: Adherence to intravitreal aflibercept in neovascular age-related macular degeneration: 24-month results from the ANDROMEDA Study (Ophthalmol. Retina. 2026;10:241-249).. Ophthalmology. Retina. https://doi.org/10.1016/j.oret.2026.06.013

Source records